X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SANOFI INDIA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SANOFI INDIA ALEMBIC LTD/
SANOFI INDIA
 
P/E (TTM) x 53.9 33.8 159.8% View Chart
P/BV x 2.2 6.4 34.1% View Chart
Dividend Yield % 0.5 0.6 78.6%  

Financials

 ALEMBIC LTD   SANOFI INDIA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
SANOFI INDIA
Dec-17
ALEMBIC LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs724,945 1.5%   
Low Rs343,901 0.9%   
Sales per share (Unadj.) Rs4.71,081.8 0.4%  
Earnings per share (Unadj.) Rs6.1141.6 4.3%  
Cash flow per share (Unadj.) Rs6.2185.9 3.4%  
Dividends per share (Unadj.) Rs0.2033.00 0.6%  
Dividend yield (eoy) %0.40.7 50.6%  
Book value per share (Unadj.) Rs40.7868.8 4.7%  
Shares outstanding (eoy) m267.0323.03 1,159.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.1 275.5%   
Avg P/E ratio x8.731.2 27.8%  
P/CF ratio (eoy) x8.523.8 35.6%  
Price / Book Value ratio x1.35.1 25.6%  
Dividend payout %3.323.3 14.1%   
Avg Mkt Cap Rs m14,139101,862 13.9%   
No. of employees `000NA3.2 0.0%   
Total wages/salary Rs m2073,685 5.6%   
Avg. sales/employee Rs ThNM7,691.9-  
Avg. wages/employee Rs ThNM1,137.7-  
Avg. net profit/employee Rs ThNM1,006.5-  
INCOME DATA
Net Sales Rs m1,25524,914 5.0%  
Other income Rs m370807 45.9%   
Total revenues Rs m1,62525,721 6.3%   
Gross profit Rs m1115,372 2.1%  
Depreciation Rs m381,022 3.7%   
Interest Rs m211 15.5%   
Profit before tax Rs m4425,146 8.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,886 1.3%   
Profit after tax Rs m1,6303,260 50.0%  
Gross profit margin %8.921.6 41.0%  
Effective tax rate %5.436.6 14.8%   
Net profit margin %129.813.1 992.3%  
BALANCE SHEET DATA
Current assets Rs m1,86714,432 12.9%   
Current liabilities Rs m5916,010 9.8%   
Net working cap to sales %101.633.8 300.7%  
Current ratio x3.22.4 131.5%  
Inventory Days Days9461 154.8%  
Debtors Days Days7428 258.2%  
Net fixed assets Rs m1,7917,991 22.4%   
Share capital Rs m534230 231.9%   
"Free" reserves Rs m10,32419,778 52.2%   
Net worth Rs m10,85820,008 54.3%   
Long term debt Rs m410-   
Total assets Rs m11,59127,770 41.7%  
Interest coverage x260.9468.8 55.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.10.9 12.1%   
Return on assets %14.111.8 119.5%  
Return on equity %15.016.3 92.1%  
Return on capital %15.225.8 58.9%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m196,306 0.3%   
Fx outflow Rs m2645,257 5.0%   
Net fx Rs m-2441,049 -23.3%   
CASH FLOW
From Operations Rs m2364,351 5.4%  
From Investments Rs m-224-787 28.5%  
From Financial Activity Rs m-27-1,884 1.4%  
Net Cashflow Rs m-151,680 -0.9%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 0.2 14.4 1.4%  
FIIs % 9.7 14.6 66.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 10.5 248.6%  
Shareholders   54,701 15,184 360.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   AUROBINDO PHARMA  MERCK  GSK PHARMA  J.B.CHEMICALS  STRIDES PHARMA SCIENCE  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Turn Volatile; Realty & IT Stocks Gain(12:30 pm)

Share markets in India are presently trading on a flat note. Sectoral indices are trading mixed with stocks in the realty sector and IT sector.

Related Views on News

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Mar 20, 2019 02:55 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS